These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34610820)

  • 1. Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis.
    Vlachaki I; Vacchelli M; Zinzi D; Falla E; Jiang Y; Mantopoulos T; Nathwani D
    BMC Infect Dis; 2021 Oct; 21(1):1036. PubMed ID: 34610820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    McCool R; Gould IM; Eales J; Barata T; Arber M; Fleetwood K; Glanville J; Kauf TL
    BMC Infect Dis; 2017 Jan; 17(1):39. PubMed ID: 28061827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
    O'Riordan W; McManus A; Teras J; Poromanski I; Cruz-Saldariagga M; Quintas M; Lawrence L; Liang S; Cammarata S;
    Clin Infect Dis; 2018 Aug; 67(5):657-666. PubMed ID: 29518178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
    Giordano PA; Pogue JM; Cammarata S
    Clin Infect Dis; 2019 Apr; 68(Suppl 3):S223-S232. PubMed ID: 30957167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin.
    Righi E; Carnelutti A; Vena A; Bassetti M
    Infect Drug Resist; 2018; 11():479-488. PubMed ID: 29670380
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    McCurdy S; Lawrence L; Quintas M; Woosley L; Flamm R; Tseng C; Cammarata S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.
    Logman JF; Stephens J; Heeg B; Haider S; Cappelleri J; Nathwani D; Tice A; van Hout BA
    Curr Med Res Opin; 2010 Jul; 26(7):1565-78. PubMed ID: 20429820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    Saravolatz LD; Pawlak JM; Wegner C
    J Antimicrob Chemother; 2020 Sep; 75(9):2605-2608. PubMed ID: 32542310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Lodise TP; Low DE
    Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials.
    Lan SH; Lai CC; Lu LC; Chang SP; Huang HT
    Infect Drug Resist; 2019; 12():1415-1423. PubMed ID: 31213859
    [No Abstract]   [Full Text] [Related]  

  • 11. The Efficacy and Adverse Events of Delafloxacin for Treating Acute Bacterial Skin and Skin Structure Infections: A Systematic Review and Meta-Analysis.
    Tanvir SB; Qasim SSB; Latimer J; Qamar Z; Niazi FH
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S538-S545. PubMed ID: 33149517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.
    Pullman J; Gardovskis J; Farley B; Sun E; Quintas M; Lawrence L; Ling R; Cammarata S;
    J Antimicrob Chemother; 2017 Dec; 72(12):3471-3480. PubMed ID: 29029278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials.
    Alhifany AA; Bifari N; Alatawi Y; Malik SU; Almangour TA; Altebainawi AF; Alshammari TM; Alotaibi AF; Mahrous AJ; Alshehri FS; Cheema E
    Saudi Pharm J; 2022 Mar; 30(3):195-204. PubMed ID: 35498222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.
    Thom H; Thompson JC; Scott DA; Halfpenny N; Sulham K; Corey GR
    Curr Med Res Opin; 2015 Aug; 31(8):1539-51. PubMed ID: 26038985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Cadena J; Javeri H
    Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M; Hsu DI
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delafloxacin for the treatment of respiratory and skin infections.
    Bassetti M; Della Siega P; Pecori D; Scarparo C; Righi E
    Expert Opin Investig Drugs; 2015 Mar; 24(3):433-42. PubMed ID: 25604710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia.
    Zhang Y; Wang Y; Van Driel ML; McGuire TM; Zhang T; Dong Y; Liu Y; Liu L; Hao R; Cao L; Xing J; Dong Y
    Antimicrob Resist Infect Control; 2019; 8():72. PubMed ID: 31080587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
    Kingsley J; Mehra P; Lawrence LE; Henry E; Duffy E; Cammarata SK; Pullman J
    J Antimicrob Chemother; 2016 Mar; 71(3):821-9. PubMed ID: 26679243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.